Exporter Supply Landscape

Supplier countries for containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, (not packaged for retail sale)

A reported trade view for HS 300349, with available observations through 2024.

HS6 300349Coverage 1995-2024Updated 2026-08-14
Explore this product

Leading supplier

Ireland$40.2M

Supplier countries

162Reported suppliers

Top supplier reach

18Destination markets

Latest global trade

$130.7MYear: 2024

Reported observations

Supplier evidence

Supplier countries ranked by latest reported export value.

SupplierLatest exports5-year growthDestinationsLeading destination
Ireland$40.2M+139.9%18Malaysia
USA$32.2M+34.3%48France
Germany$28.0M-34.9%25United Kingdom
Romania$21.6M+40.3%19Hungary
United Kingdom$20.4M-37.7%20Slovakia
China$10.6M+13.5%24Japan
France$7.8M+50.8%32Saudi Arabia
India$6.1M+32.2%48USA
Italy$5.0M+22.5%19United Kingdom
Netherlands$4.3M-22.6%16Libya
Slovenia$3.6M+85.5%4Iran
Taiwan$3.4M+126%1USA
Denmark$3.3M+24.4%9Iran
Australia$3.3M+15.1%12New Zealand
Singapore$3.2M+87.8%3Spain
Bangladesh$2.3M-74.4%2Myanmar
Spain$2.3M+14.1%25Belgium
Switzerland, Liechtenstein$2.1M-10.6%11Estonia
Austria$2.0M+20.7%7Italy
Czechia$1.6M-53.4%3Slovakia
Sweden$1.6M-25.4%7Iran
Slovakia$1.6M+36.5%4Canada
Israel$1.5M+873.5%4Turkey
Portugal$1.3M+41.1%5Saudi Arabia
Belgium$1.3M-51.2%10Ireland
Bulgaria$1.1M-81.7%1Germany
Saudi Arabia$1.0M-46.2%2United Arab Emirates
Thailand$860.6K-39%1Indonesia
Japan$837.9K-24.3%7Egypt
Russia$818.7K-84%1Belarus
Canada$799.3K-26.6%9Panama
United Arab Emirates$783.3K+105.8%8Panama
Latvia$754.6K-51.4%1Greece
South Africa$743.2K-26.7%15Lesotho
Cyprus$726.4K+121%4Netherlands

Market reading

Which countries supply containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, (not packaged for retail sale)?

Ireland is the leading reported supplier in this view, with exports of $40.2M.

How to use this view

Start with the leading rows in the first table, then use the chart to compare supplier scale and destination reach for containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (inn) or norephedrine or their salts: for therapeutic or prophylactic uses, (not packaged for retail sale). The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Supplier corridor unit-value evidence

Reported corridor unit values for the selected supplier, compared with each buyer market's median.

Buyer marketReported yearTrade valueQuantityUnit value USD/tonBuyer-market median USD/ton
Hungary2023$14.8M7 t$2,096,957.97$385,081.08
Viet Nam2023$14.7M455.5 t$32,251.2$32,251.2
Egypt2023$11.7M357.8 t$32,740.47$32,740.47
Malaysia2023$878.7K5.3 t$164,737.91$156,111.11
Italy2023$424.5K3.5 t$121,379.47$137,500
Algeria2023$78.9K1.9 t$42,169.43$42,169.43
Lesotho2023$76.4K5.4 t$14,255.79$20,000
Spain2023$23.7K18.1 t$1,304.71$196,214.29
Andorra2023$14.2K0 t$3,548,500$3,548,500
Germany2023$7.9K0 t$202,205.13$158,000
Saudi Arabia2023$4.2K0 t$350,250$350,250
Netherlands2023$584.00 t$116,800$53,882.35
Canada2023$516.00.1 t$9,555.56$9,936.78
USA2023$222.00 t$74,000$382,400
India2023$74.00 t$74,000$74,000
Hungary2022$57.1M3.8 t$15,214,656.8$370,000
Italy2022$2.5M9.6 t$260,859.24$526,399.52
Malaysia2022$1.1M6.3 t$175,626.55$180,000
Algeria2022$254.3K12.3 t$20,647.88$33,183.79
Viet Nam2022$198.8K6.3 t$31,675.7$194,235.29

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.